Regulation of chemokines, CCL3 and CCL4, by interferon γ and nitric oxide synthase 2 in mouse macrophages and during salmonella enterica serovar typhimurium infection

Journal of Infectious Diseases

Volumn 207, Issue 10, 2013, Pages 1556-1568

  Chandrasekar, Bhagawat ^a   Deobagkar Lele, Mukta ^a   Victor, Emmanuel S ^a   Nandi, Dipankar ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

chemokines; cytokine; infection; interferon ; macrophages; nitric oxide; nitric oxide synthase 2

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INDUCIBLE NITRIC OXIDE SYNTHASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE P38; STAT1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BONE MARROW CELL; C57BL 6 MOUSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXUDATE; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION; SALMONELLA TYPHIMURIUM; SEROTYPE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR ALPHA BLOOD LEVEL; TYPHOID FEVER;

ACTIVATING TRANSCRIPTION FACTOR 3; ANIMALS; CHEMOKINE CCL3; CHEMOKINE CCL4; CHEMOKINE CXCL10; GENE EXPRESSION REGULATION; INTERFERON-GAMMA; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; STAT1 TRANSCRIPTION FACTOR; STEM CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84876562902     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit067     Document Type: Article

References (50)

1. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-gamma. Annu Rev Immunol 1997; 15:749-95.
2. Saha B, Jyothi Prasanna S, Chandrasekar B, Nandi D. Gene modulation and immunoregulatory roles of interferon gamma. Cytokine 2010; 50:1-14.
3. Ottenhoff TH, Kumararatne D, Casanova JL. Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria. Immunol Today 1998; 19:491-4. (Pubitemid 28518024)
4. Platanias LC. Mechanisms of type-I-and type-II-interferon-mediated signalling. Nat Rev Immunol 2005; 5:375-86.
5. Meraz MA, White JM, Sheehan KC, et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 1996; 84:431-42. (Pubitemid 26058568)
6. Bhosale M, Kadthur JC, Nandi D. Roles of Salmonella enterica serovar Typhimurium encoded Peptidase N during systemic infection of Ifnγ?/? mice. Immunobiology 2012; 217:354-62.
7. Valledor AF, Sánchez-Tilló E, Arpa L, et al. Selective roles of MAPKs during the macrophage response to IFN-gamma. J Immunol 2008; 180:4523-9.
8. Su SB, Grajewski RS, Luger D, et al. Altered chemokine profile associated with exacerbated autoimmune pathology under conditions of genetic interferon-gamma deficiency. Invest Ophthalmol Vis Sci 2007; 48:4616-25. (Pubitemid 351260979)
9. Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 2002; 168:3195-204. (Pubitemid 34256349)
10. Lee SC, Brummet ME, Shahabuddin S, et al. Cutaneous injection of human subjects with macrophage inflammatory protein-1 alpha induces significant recruitment of neutrophils and monocytes. J Immunol 2000; 164:3392-401. (Pubitemid 30149006)
11. DiPietro LA, Burdick M, Low QE, Kunkel SL, Strieter RM. MIP-1alpha as a critical macrophage chemoattractant in murine wound repair. J Clin Invest 1998; 101:1693-8. (Pubitemid 28198499)
12. Karpus WJ, Lukacs NW, McRae BL, Strieter RM, Kunkel SL, Miller SD. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J Immunol 1995; 155:5003-10.
13. Cameron MJ, Arreaza GA, Grattan M, et al. Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes. J Immunol 2000; 165:1102-10. (Pubitemid 30484782)
14. Crane IJ, Xu H, Manivannan A, et al. Effect of anti-macrophage inflammatory protein-1alpha on leukocyte trafficking and disease progression in experimental autoimmune uveoretinitis. Eur J Immunol 2003; 33:402-10. (Pubitemid 36267604)
15. Olszewski MA, Huffnagle GB, Traynor TR, McDonald RA, Cook DN, Toews GB. Regulatory effects of macrophage inflammatory protein 1alpha/CCL3 on the development of immunity to Cryptococcus neoformans depend on expression of early inflammatory cytokines. Infect Immun 2001; 69:6256-63. (Pubitemid 32885189)
16. Lindell DM, Standiford TJ, Mancuso P, Leshen ZJ, Huffnagle GB. Macrophage inflammatory protein 1alpha/CCL3 is required for clearance of an acute Klebsiella pneumoniae pulmonary infection. Infect Immun 2001; 69:6364-9. (Pubitemid 32885201)
17. Takahashi H, Tashiro T, Miyazaki M, Kobayashi M, Pollard RB, Suzuki F. An essential role of macrophage inflammatory protein 1alpha/CCL3 on the expression of host's innate immunities against infectious complications. J Leukoc Biol 2002; 72:1190-7. (Pubitemid 36008890)
18. Domachowske JB, Bonville CA, Gao JL, Murphy PM, Easton AJ, Rosenberg HF. The chemokine macrophage-inflammatory protein-1 alpha and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection. J Immunol 2000; 165:2677-82. (Pubitemid 30660717)
19. Dragic T, Litwin V, Allaway GP, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996; 381:667-73. (Pubitemid 26197680)
20. Alkhatib G, Combadiere C, Broder CC, et al. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophagetropic HIV-1. Science 1996; 272:1955-8. (Pubitemid 26234510)
21. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995; 270:1811-5.
22. Malu S, Srinivasan S, Kumar Maiti P, Rajagopal D, John B, Nandi D. IFN-gamma bioassay: development of a sensitive method by measuring nitric oxide production by peritoneal exudate cells from C57BL/6 mice. J Immunol Methods 2003; 272:55-65. (Pubitemid 36050745)
23. Frank DA, Mahajan S, Ritz J. Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling. Nat Med 1999; 5:444-7. (Pubitemid 29180586)
24. Prasanna SJ, Saha B, Nandi D. Involvement of oxidative and nitrosative stress in modulation of gene expression and functional responses by IFNgamma. Int Immunol 2007; 19:867-79. (Pubitemid 47241895)
25. Olken NM, Marletta MA. NG-methyl-L-arginine functions as an alternate substrate and mechanism-based inhibitor of nitric oxide synthase. Biochemistry 1993; 32:9677-85. (Pubitemid 23296812)
26. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997; 15:323-50. (Pubitemid 27169284)
27. Wang SW, Pawlowski J, Wathen ST, Kinney SD, Lichenstein HS, Manthey CL. Cytokine mRNA decay is accelerated by an inhibitor of p38-mitogen-activated protein kinase. Inflamm Res 1999; 48:533-8. (Pubitemid 29495635)
28. Chromik AM, Hahn SA, Daigeler A, et al. Gene expression analysis of cell death induction by taurolidine in different malignant cell lines. BMC Cancer 2010; 10:595.
29. Alam MS, Akaike T, Okamoto S, et al. Role of nitric oxide in host defense in murine salmonellosis as a function of its antibacterial and antiapoptotic activities. Infect Immun 2002; 70:3130-42. (Pubitemid 34564176)
30. Haskó G, Shanley TP, Egnaczyk G, et al. Exogenous and endogenous catecholamines inhibit the production of macrophage inflammatory protein (MIP) 1 alpha via a beta adrenoceptor mediated mechanism. Br J Pharmacol 1998; 125:1297-1303. (Pubitemid 28542540)
31. Michl J, Pieczonka MM, Unkeless JC, Silverstein SC. Effects of immobilized immune complexes on Fc-and complement-receptor function in resident and thioglycollate-elicited mouse peritoneal macrophages. J Exp Med 1979; 150:607-21. (Pubitemid 9250732)
32. Rapisarda A, Pastorino S, Massazza S, Varesio L, Bosco MC. Antagonistic effect of picolinic acid and interferon-gamma on macrophage inflammatory protein-1alpha/beta production. Cell Immunol 2002; 220:70-80. (Pubitemid 36444500)
33. Ohmori Y, Hamilton TA. Requirement for STAT1 in LPS-induced gene expression in macrophages. J Leukoc Biol 2001; 69:598-604. (Pubitemid 32294845)
34. Thomassen MJ, Buhrow LT, Connors MJ, Kaneko FT, Erzurum SC, Kavuru MS. Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages. Am J Respir Cell Mol Biol 1997; 17:279-83. (Pubitemid 127500831)
35. Sherry B, Schmidtmayerova H, Zybarth G, Dubrovsky L, Raabe T, Bukrinsky M. Nitric oxide regulates MIP-1alpha expression in primary macrophages and T lymphocytes: implications for anti-HIV-1 response. Mol Med 2000; 6:542-9.
36. Chang C-I, Liao JC, Kuo L. Arginase modulates nitric oxide production in activated macrophages. A. J. Physiol 1998; 274:H342-8.
37. Pollack BP, Sapkota B, Haun PL. Activating transcription factor 3 (ATF3) expression is increased in erythema multiforme and is regulated by IFN-gamma in human keratinocytes. Exp Dermatol 2010; 19:e310-3.
38. Khuu CH, Barrozo RM, Hai T, Weinstein SL. Activating transcription factor 3 (ATF3) represses the expression of CCL4 in murine macrophages. Mol Immunol 2007; 44:1598-1605.
39. Hartman MG, Lu D, Kim ML, et al. Role for activating transcription factor 3 in stress-induced beta-cell apoptosis. Mol Cell Biol 2004; 24:5721-32. (Pubitemid 38787958)
40. Lu D, Chen J, Hai T. The regulation of ATF3 gene expression by mitogen-activated protein kinases. Biochem J 2007; 401:559-67. (Pubitemid 46166437)
41. Lahti A, Kankaanranta H, Moilanen E. P38 mitogen-activated protein kinase inhibitor SB203580 has a bi-directional effect on iNOS expression and NO production. Eur J Pharmacol 2002; 454:115-23. (Pubitemid 35287470)
42. Strle K, Drouin EE, Shen S, et al. Borrelia burgdorferi stimulates macrophages to secrete higher levels of cytokines and chemokines than Borrelia afzelii or Borrelia garinii. J Infect Dis 2009; 200:1936-43.
43. Goletti D, Carrara S, Vincenti D, et al. Inhibition of HIV-1 replication in monocyte-derived macrophages by Mycobacterium tuberculosis. J Infect Dis 2004; 189:624-33. (Pubitemid 38270915)
44. Zhou Y, Kurihara T, Ryseck R-P, et al. Impaired macrophage function and enhanced T cell dependent immune response in mice lacking Ccr5, the mouse homologue of the major HIV1 coreceptor. J Immunol 1998; 160:4018-25. (Pubitemid 28176111)
45. Algood HMS, Flynn J. Ccr5-deficient mice control Mycobacterium tuberculosis infection despite increased pulmonary lymphocytic infiltration. J. Immunol 2004; 173:3287-96. (Pubitemid 39142037)
46. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993; 178:2249-54. (Pubitemid 23344886)
47. Huang S, Hendriks W, Althage A, et al. Immune response in mice that lack the interferon-gamma receptor. Science 1993; 259:1742-5. (Pubitemid 23114659)
48. Karupiah G, Xie QW, Buller RM, Nathan C, Duarte C, MacMicking JD. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 1993; 261:1445-8. (Pubitemid 23334265)
49. Machado FS, Souto JT, Rossi MA, et al. Nitric oxide synthase-2 modulates chemokine production by Trypanosoma cruzi-infected cardiac myocytes. Microbes Infect 2008; 10:1558-66.
50. Repeke CE, Ferreira SB, Claudino M, et al. Evidences of the cooperative role of the chemokines CCL3, CCL4 and CCL5 and its receptors CCR1+ and CCR5+ in RANKL+ cell migration throughout experimental peridontitis in mice. Bone 2010; 46:1122-1130.